(Q36836275)

16 August 2017

1 reference

title

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities (English)

1 reference

16 August 2017

Christophe Mariette

1

1 reference

16 August 2017

Guillaume Piessen

series ordinal

2

1 reference

16 August 2017

Jean-Pierre Triboulet

series ordinal

3

1 reference

16 August 2017

language of work or name

1 reference

1 June 2007

1 reference

Lancet Oncology Commission

16 August 2017

published in

1 reference

16 August 2017

volume

8

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

545-553

1 reference

Systemic treatment for oesophageal cancer

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

[Esophagectomy by triple approach: primary thoracotomy, laparotomy, and cervicotomy - The MacKeown Procedure]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Should en bloc esophagectomy be the standard of care for esophageal carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Surgery alone in the curative treatment of localised oesophageal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Hospital volume and surgical mortality in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Preoperative radiotherapy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

[Radical nature and life expectancy in the surgical treatment of esophageal and cardial carcinoma]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Japanese Esophageal Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Induction chemotherapy in the treatment of patients with carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Is preoperative chemoradiation effective in treatment of oesophageal carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Nonoperative therapy for squamous-cell cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous rese

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970172-9

7 January 2021

10.1016/S1470-2045(07)70172-9

Identifiers

DOI

1 reference

16 August 2017

1 reference